34
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Social Pharmacology: Unresolved Critical Issues

&
Pages 1647-1737 | Published online: 03 Jul 2009

References

  • Erson W. T., . The physician-patient encounter: A process of reality negotiation. Patients, Physicians and Illness., E. G. Jaco, et al. The Free Press, New York 1979; 259–271
  • Erson L. A., et al. Effects of modeling patient communication, satisfaction and knowledge. Med. Care 1987; 25: 1044–1056
  • Annas G. J. Informed consent. Annu. Rev. Med. 1978; 29: 9–14
  • Mental Mirrors—Metacognition in Social Knowledge and Communication, C. Antaki, et al. Sage, London 1986
  • Applebaum P. S. The right to refuse treatment with antipsychotic medications: Retrospect and prospect. Am. J. Psychiatry 1988; 145: 413–419
  • Apter M. J. Motivation. A Lexicon of Psychology, Psychiatry and Psychoanalysis, J. Kuper. Routledge, London 1988
  • Ascione F. J., et al. Physicians' attitudes regarding patients' knowledge of prescribed medications. Am. Pharm. Assoc. 1975; NS15: 386–390
  • Ascione F. J., et al. The effectiveness of four education strategies in die elderly. Drug. Int. Gin. Pharm. 1984; 18: 926–931
  • Ashton H. Risk of dependence on benzodiazepine drugs: A major problem of longterm treatment. Br. Med. J. 1989; 298: 103–104
  • Ashton H. Protracted withdrawal syndromes from benzodiazepines. J. Subst. Abuse Treatm. 1991; 8: 19–28
  • Asplund T., et al. Pensionärers bruk av psykofarmaka [Elderly people's use of psychotropics]. Sv. Farm. Tidskr. 1983; 87(8)24–28
  • ASTON UNIVERSITY. Consumer Expectations and Community Pharmaceutical Services. Aston University, Birmingham 1991
  • Avorn J., et al. Improving drug-therapy decisions through educational outreach. N. Engl. J. Med. 1983; 308: 1457–1463
  • Avorn J., et al. The neglected medical history and therapeutic choices for abdominal pain. Arch. Intern. Med. 1991; 151: 694–698
  • Baaksas I., et al. Patient reaction to information and motivation factors in long-term treatment with antihypertensive drugs. Acta Med. Scand. 1980; 207: 407–412
  • Backe B., et al. General practitioners' attitudes to oestrogen prescription in the menopause: A national survey of Norway. Scand. J. Prim. Health Care 1992; 10: 179–184
  • Balint M., et al. Treatment or diagnosis? A Study of Repeat Prescriptions in General Practice. Tavistock Publ, London 1970
  • Balter M. B., et al. Cross-national study of the extent of anti-anxiety/sedative drug use. N. Engl. J. Med. 1974; 290: 769–774
  • Balter M. B., et al. A cross-national comparison of anti-anxiety/sedative drug use. Current Med. Res. Opin. 1984; 8: 5–20, Suppl
  • Balter M. B., et al. The beneficial and adverse effects of hypnotics. J. Clin. Psychiatry 1991; 52(7)16–21
  • Barnas C, et al. Characteristics of benzodiazepine long-term users: Investigations of benzodiazepine consumers among pharmacy customers. Psychopharmacology 1991; 103: 233–239
  • Barnett A., et al. The economics of pharmaceutical policy in Ghana. Int. J. Health Serv. 1980; 10: 479–499
  • Becker M. H., et al. Characteristics and attitude of physicians associated with the prescribing of chloramphenicol. HSMHA Health Rep. 1971; 86: 993–1003
  • Becker M. H., et al. Differential education concerning therapeutics and resultant physician prescribing patterns. J. Med. Educ. 1972a; 47: 118–127
  • Becker M. H., et al. Motivations as predictors of health behaviour. Health Serv. Rep. 1972b; 87: 852–862
  • Becker M. H., et al. A family approach to compliance with medical treatment. Int. J. Health Educ. 1975; 18: 173–182
  • Becker D. M., et al. Decision to adopt new medical technology: A case study of thrombolytic therapy. Soc. Sci. Med. 1985; 21: 291–298
  • Benson P. Informed consent—Drug information to patients prescribed antipsychotic medication. J. Nerv. Ment. Dis. 1984; 172: 642–653
  • Berzonsky M. D. Self-theorists, identity status and social cognition. Self, Ego and Identity—Integrative Approaches, D. K. Lapsley, et al. Springer Verlag, New York 1988; 243–262
  • Binz U. Das Placebo-Phanomen. Dissertation, University of Mannheim, MannheimGermany 1977
  • Bjerke E., et al. Efekt av tilbakemedling og selvevaluering på forskrivning av beroligende midler [The effects of physician self-monitoring on the prescribing of drugs which may lead to dependence]. Tidskr. Nor. Laegeforen. 1991; 11: 2246–2248
  • Blackwell B. Treatment adherence in hypertension. Am. J. Pharm. Assoc. 1976a; 16: 75–85
  • Blackwell B. Treatment adherence. Br. J. Psychiatry 1976b; 129: 513–531
  • Bledsoe C. H., et al. The interpretation of Western pharmaceuticals among the Mende of Sierra Leone. Soc. Sci. Med. 1985; 21: 275–282
  • Bloomgarden Z. T., et al. Randomized, controlled trial of diabetic patient education: Improved knowledge without improved metabolic status. Diabetes Care 1987; 10: 263–272
  • Bodewitz H., et al. The strange case of Metoprolol: One agent—Two drugs. Paper presented at 4th European Workshop of Social Pharmacy. Stockholm Sept., 1986; 8–10
  • Patient Package Insert as a Source of Drug Information, M. Bogaert, et al. Excerpta Medica, Amsterdam 1989
  • Bogdan R., et al. Introduction to Qualitative Research Methods. Wiley, New York 1975
  • Bok S. The ethics of giving placebos. Sci. Am. 1974; 231: 17–23
  • Bonnema J., et al. The abuse of high dose estrogen/progestin combination drugs in delay of menstration: The assumptions and practices of doctors, midwives and pharmacists in a Peruvian city. Soc. Sci. Med. 1992; 34: 281–289
  • Bourhis R. Y., et al. Communication in the hospital setting: A survey of medical and everyday language use amongst patients, nurses and doctors. Soc. Sci. Med. 1989; 28: 339–346
  • Bowers K. S. Intuition and discovery. Theories of the Unconscious and Theories of the Self, R. Stern. Analytical Press, Hillsdale, NJ 1987; 71–90
  • Bowler M. H., et al. A small group strategy for improving compliance behaviour and blood pressure control. Health Educ. Q. 1983; 10(1)56–69
  • Bradshaw P. W., et al. Recall of medical advice: Comprehension and specificity. Br. J. Soc. Clin Psychol. 1975; 14: 55–62
  • Brehmer B. In one word: Not from experience. Acta Psychol. 1980; 45: 223–241
  • Brodsky C. M., et al. Analysis of treatment-decision system. Dis. Nerv. System 1969; 30: 17–23
  • Brody H. Placebos and the Philosophy of Medicine—Ethical, Conceptual and Ethical Issues. University of Chicago Press, Chicago 1980
  • Brown C. S., et al. Association between type of medication instruction and patients' knowledge, side effects and compliance. Hosp. Commun. Psychiatr. 1987; 38: 55–60
  • Bruun K., et al. Controlling Psychotropic Drugs: The Nordic Experience. Croom Helm, London 1983
  • Bursten B. Medication nonadherence due to the feeling of loss of control in “biological depression.”. Am. J. Psychiatry 1985; 142: 244–246
  • Busson M., et al. Patients' knowledge about prescribed medicine. Pharm. J. May 1986; 17: 624–626
  • Busto U., et al. Withdrawal reaction after long-term therapeutic use of benzodiazepines. N. Engl. J. Med. 1986; 315: 854–859
  • Cady P. S., et al. Satisfaction-dissatisfaction with prescription medication: the impact of drug information. J. Pharm. Mark. Management 1989; 4: 3–24
  • Caplan R. D., et al. Social effects of diazepam use—A longitudinal field study. Soc. Sci. Med. 1985; 21: 887–898
  • Caplow T., et al. Pattern of prescribing in general practice. Br. Med. J. 1954; 2: 604–607
  • Caron H. S., et al. Patients' cooperating with a medical regimen. JAMA 1968; 203(11)120–124
  • Carter B. L., et al. Evaluation of family physician prescribing: Influences from the clinical pharmacist. Drug Intell. Clin. Pharm. 1984; 18: 817–821
  • Cartwright A., et al. Elderly People, Their Medicine and Their Doctors. Routledge, London 1988
  • Carey D. L., et al. An attempt to influence hypnotic and sedative drug use. Med. J. Aust. 1992; 156: 389–396
  • Catalan J., et al. The effects of non-prescribing of anxiolytic in general practice. Br. J. Psychiatry 1984; 144: 593–602
  • Catalan J., et al. Benzodiazepines in general practice: Time for a decision. Br. Med. J. 1985; 290: 1374–1376
  • Chinburapa V., et al. Prescribing intention and the relative importance of drug attributes. J. Pharm. Mark. Management 1987; 2: 89–105
  • Chinburapa V., et al. Predicting prescribing intention and assessing drug attribute importance during conjoint analysis. J. Pharm. Mark. Management 1988; 3(2)3–18
  • Chinburapa V., et al. The importance of side effects and outcomes in differentiating between prescription drug products. J. Clin. Pharm. Ther. 1992; 17: 333–342
  • Chinburapa V., et al. Physician prescribing decisions: The effects of situational involvement and task complexity on information acquisation and decision-making. Soc. Sci. Med. 1993; 36: 1473–1482
  • Chirac P., et al. Drug marketing in French-speaking African countries. Soc. Sci. Med. 1993; 36: 1541–1543
  • Christensen D. B., et al. Sources of information and influence on new drug prescribing among physicians in an HMO. Soc. Sci. Med. 1979; 13A: 313–322
  • Christensen D. B., et al. Drug prescribing: Patterns, problems and proposals. Soc. Sci. Med. 1981; 15A: 343–355
  • Christensen D. B. Understanding patient drug-taking compliance. J. Soc. Adm. Pharm. 1985; 3: 70–77
  • Cialdella P., et al. Prescription intentions in the relation to therapeutic information: A study of 117 French general practitioners. Soc. Sci. Med. 1991; 33: 1263–1274
  • Clare A. The benzodiazepine controversy: A psychiatrist's reaction. Understanding Tranquilizer Use, J. Gabe. Tavistock/Routledge, London 1991; 180–189
  • Clark C. M., et al. Evaluation of the use of programmed instruction for patients maintained on warfarin therapy. Am. J. Public Health 1972; 62: 1135–139
  • Clinite J. C, et al. Improving patient compliance. J. Am. Pharm. Assoc. Feb., 1976; 85: 74–76
  • Closser M. H. Benzodiazepines and the elderly. J. Subst. Abuse Treatment 1991; 8: 35–41
  • Cochrane R. A., et al. Changes in drug treatment after discharge from hospital in geriatric patients. Br. Med. J. 1992; 305: 694–696
  • Coleman J. S., et al. Medical Innovation: A Diffusion Study. Bobbs-Merrill, Indianapolis 1966
  • COMMITTEE OF THE INSTITUTE FOR BEHAVIOR AND HEALTH INC., Abuse of benzodiazepines. Am. J. Drug Alcohol Abuse 1988; 14: 1–67, Supp 1
  • Conrad P. The meaning of medications: Another look at compliance. Soc. Sci. Med. 1985; 20: 29–37
  • Conrad P. Qualitative research on chronic illness: A commentary on method and conceptual development. Soc. Sci. Med. 1990; 30: 1257–1263
  • Cooper J. K., et al. Intentional prescription nonadherence (noncompliance) by the elderly. J. Am. Geriatr. Soc. 1982; 329–333; 1982
  • Cooperstock R. Sex differences in psychotropic drugs. Soc. Health Illness 1978; 12B: 179–186
  • Cooperstock R. Some comments on the clinical appropriateness of prescribing psychoactive drugs. Society and Medication: Conflicting Signals for Prescribes and Patients., J. P. Morgan, et al. Lexington Books, Lexington, MA 1983; 155–162
  • Cooperstock R., et al. Some social meanings of tranquilizer use. Soc. Sci. Med. 1979; 1: 331–347
  • Cooperstock R., et al. Research on psychotropic drug use—A review of findings and methods. Soc. Sci. Med. 1982; 16: 1179–1196
  • Cormack M. A., et al. The effect of minimal interventions by general practitioners on long term bcnsodiazepine use. J. Roy. Coll. Gen. Pract. 1989; 39: 408–411
  • Cormack M. A., et al. Factors linked to the prescribing of benzodiazepines by general practice principals and trainees. Fam. Prac. 1992; 9: 466–471
  • Cramer J. A., et al. How often is medication taken as prescribed?. JAMA 1989; 261: 3273–3277
  • Cronquist I., et al. Läkemedelsinfomation i primärvarden [Drug information in primary care]. Inst. f. klinisk samhällsmedicin. Lunds Universitet, Lund 1987
  • Crouch G., et al. Benzodiazepine dependent patients and their psychological treatment. Prog. Neuro-Psychopharmacol. Psychiatry 1988; 12: 503–510
  • Culbertson V. L., et al. Consumer preferences for verbal and written medication information. Drug. Int. Clin. Pharm. 1988; 22: 390–396
  • Damsgaard J. J., et al. Effects of local interventions towards prescribing of psychotropic drugs. J. Soc. Adm. Pharm. 1992; 9: 179–184
  • Darr M. S., et al. Content and retention evaluation of an audiovisual patient-education program on bronchodilators. Am. J. Hosp. Pharm. 1981; 38: 672–675
  • Davis M. S. Variations in patients' compliance with doctors' orders: Analysis of congruence between survey responses and results of empirical investigations. J. Med. Educ. 1966; 41: 1037–1048
  • De Blaquiere P., et al. Use and misuse of metered-dose inhalers by patients with chronic lung disease. Am. Rev. Respir. Dis. 1989; 140: 910–916
  • Deberry P., et al. Teaching cardiac patients to manage medications. Am. J. Nurs. 1975; 75: 2191–2193
  • Declerque J., et al. Rumor, misinformation and oral contraceptive use in Egypt. Soc. Sci. Med. 1986; 23: 83–92
  • Deikman A. The Observing Self. Beacon Press, Boston 1982
  • Denig P. Drug choice within a university hospital: Rational and reasoned. Paper presented at the 6th Social Pharmacy Workshop. Geiranger, Norway 1990
  • Denig P., et al. How physicians choose drugs. Soc. Sci. Med. 1988; 27: 1381–1386
  • Denig P., et al. Impact of drug bulletin on the knowledge, perception of drug utility and prescribing behaviour of physicians. Drug. Int. Clin. Pharm. Ann. Pharmacother. 1990; 24: 87–93
  • Denig P., et al. Towards understanding treatment preferences of hospital physicians. Soc. Sci. Med. 1993; 36: 915–924
  • Dennis P. J. Monitoring of psychotropic drug prescribing in general practice. Br. Med. J. 1979; 2: 1115–1116
  • De Veert I., et al. Attitude behaviour theories and diabetic education programes. Patient Educ. Counsel. 1989; 14: 2–19
  • De Veert I., et al. Determinats of active self-care behaviour of insulin treated patients with diabetes: Implications for diabetes education. Soc. Sci. Med. 1990; 30: 605–615
  • Dilorio C, et al. Cognitive-perceptual factors associated with antiepileptic medication compliance. Res. Nurs. Health 1991; 14: 329–338
  • Di Matteo M. R., et al. Achieving Patient Compliance. Pergamon Press, New York 1982
  • Docter R. F. Transvestites and Transsexuals. Plenum Press, New York 1988
  • Dolinsky D., et al. Application of psychological principles to the design of written patient information. Am. J. Hosp. Pharm. 1983; 40: 266–271
  • Donovan J. L., et al. Patient non-compliance: Deviance and reasoned decision-making?. Soc. Sci. Med. 1992; 34: 507–513
  • Dyer A. R., et al. J. Med. Ethics 1987; 13: 12–16
  • Eagle M. N. The psychoanalytical and the cognitive conscious. Theories of the Unconscious and Theories of the Self, R. Stern. The Analytic Press, Hillsdale, NJ 1987; 155–189
  • Eardley A. Patients' worries about radiotherapy. Evaluation of a preparatory booklet. Psychol. Health 1988; 2: 79–89
  • Eccles J. A critical appraisal of brain-mind theories. Mind and Brain—The Many-Faceted Problems, J. Eccles. Paragon House, New York 1987a; 51–57
  • Eccles J. Brain or mind, two or one?. Mindwaves—Thoughts on Intelligence, Identity and Consciousness, C. Blakemore, et al. Basil Blackwell, New York 1987b; 292–304
  • Eccles J. Evolution of the Brain—Creation of the Self. Routledge, London 1991
  • Eimerl T. S. The pattern of prescribing. J. Coll. Gen. Pract. 1962; 5: 468–479
  • Eisemon T. O., et al. Uses of formal and informal knowledge in the comprehension of instructions for oral rehydration therapy in Kenya. Soc. Sci. Med. 1987; 25: 1225–1234
  • Ekedahl A., et al. Benzodiazepine prescribing patterns in a high-prescribing Scandinavian community. Eur. J. Clin. Pharmacol. 1993; 44: 141–146
  • Endler N. S., et al. Toward an interactional psychology of personality. Psychol. Bull. 1976; 83: 956–974
  • Enlund H. Drug use and patient compliance in hypertension care in eastern Finland. Kuopio University, Kuopio 1982
  • Enlund H., et al. Problems with drug use among elderly men. J. Geriatr. Drug Ther. 1990; 4: 81–94
  • Enlund H., et al. Adverse drug effects and the need for drug information. Med. Care 1991; 29: 558–564
  • Epstein A. M., et al. Physician beliefs, attitudes and prescribing behaviour for antiinflammatory drugs. Am. J. Med. 1984; 77: 313–318
  • Evans F. J. The placebo response in pain reduction. Adv. Neurol. 1974; 4: 289–296
  • Evans C. E., et al. Educational package on hypertension for primary care physicians. Can. Med. Assoc. J. 1984; 130: 719–722
  • Evans K. R., et al. Physician perceptions of prescription drug information. J. Pharm. Mark. Management 1986; 1: 77–85
  • Evenson R. C, et al. Clinical judgement vs. multivariate furmulae in assignment of psychotropic drugs. J. Clin. Psychol. 1973; 29: 332–337
  • Evenson R. C, et al. The relationship of diagnosis and target sympoms to psychotropic drug assignment. Comprehens. Psychiatry 1974; 15: 173–178
  • Faden R. R., et al. Disclosure of information to patients in medical care. Med. Care 1981; 19: 718–733
  • Faden R. R., et al. A History and Theory of Informed Consent. Oxford University Press, New York 1986
  • Ferber R., et al. The effectiveness of pharmaceutical promotion. Bulletin Series, n. 83, Bur. Econ. and Business Adm. University of Illinois, Illinois 1958
  • Figon G., et al. Doctors' perception of pertinent information. Eur. J. Clin. Pharmacol. 1992; 43: 113–116
  • Fincham J. E. Patient compliance in the ambulatory elderly: A review of the literature. J. Ger. Drug Ther. 1988; 2(4)31–52
  • Fincham J. E., et al. Elderly patient initial noncompliance; The drug and the reasons. J. Geriatr. Drug Ther. 1988; 2(4)53–62
  • Fireman P., et al. Teaching self-management skills to asthmatic children and meir parents in an ambulatroy care setting. Pediatrics 1981; 68: 341–348
  • Fisher D. J., et al. Influence of attitudes, normative beliefs and situational variables on physicians' use of pharmacists as drug information consultants. Am. J. Hosp. Pharm. 1980; 37: 489–491
  • Fitton F., et al. The Doctor/Patient Relationship—A Study in General Practice. HMS, London 1977
  • Fleckenstein L., et al. Oral contraceptive patient information—A questionnaire study of attitudes, knowledge and preferred information sources. JAMA 1975; 235: 1331–1336
  • Fleming D. M., et al. Psychotropic drug prescribing. J. Roy. Coll. Gen. Pract. 1984; 34: 216–220
  • Fletcher S. W., et al. Patients' understanding of prescribed drugs. J. Commun. Health 1979; 4: 183–189
  • Metacognition, Cognition and Human Performance, D. L. Forrest-Pressley, et al. Academic Presss, Orlando, FL 1985; Vol 1 & 2
  • Frank J. D. The influence of patients' and therapists' expectations on the outcome of psychotherapy. Br. J. Med. Psychol. 1968; 41: 349–356
  • Frazier L. M., et al. Can physician education lower the cost of prescription drugs?. Ann. Intern. Med. 1991; 115: 116–121
  • Freemon B., et al. Gaps in doctor-patient communication: Doctor-patient interaction analysis. Pediatr. Res. 1971; 5: 298–311
  • Gabe J. Personal troubles and public issues: The sociology of long-term tranquillizer use. Understanding Tranquillizer Use—The Role of the Social Sciences, J. Gabe. Tavistock/Routledge, London 1991; 31–47
  • Gabe J., et al. Rural tranquility/ Urban-rural differences in tranquilizer prescribing. Soc. Sci. Med. 1986; 22: 1059–1066
  • Gaffin B., et al. The Fon du Luc study. Reprinted in Competitive problems in the drug industry, Hearings before the Subcommittee on Monopoly of the Select Committee on Small Business. U.S. Senate, part 1969; 14: 5811–5919
  • Gardner M., et al. A study of patients' perceived importance of medication information provided by physicians in a health maintenance organization. Drug. Int. Clin. Pharmacy 1988; 22: 596–598
  • Gardner M., et al. Effect of information organization on recall of medication instructions. J. Clin. Pharm. Ther. 1990; 15: 13–19
  • Garnett W. R., et al. Effect of telephone follow-up on medication compliance. Am. J. Hosp. Pharm. 1981; 38: 676–679
  • Gerhardt U. Ideas about Illness. Macmillan, London 1989
  • German P. S., et al. Drug side effects and doctor/patient relationship among elderly patients. J. Soc. Adm. Pharm. 1984; 2: 67–73
  • Gibbs S., et al. The benefits of prescription information leaflets. Br. J. Clin. Pharm. 1989; 27: 723–729
  • Gillis J. S., et al. An analysis of drug decisions in a state psychiatric hospital. J. Clin. Psychol. 1981; 37: 32–42
  • Gillis L. S., et al. Non-compliance with psychotropic medication. South Afr. Med. J. 1987; 72: 602–606
  • Goldberg S. R., et al. Behavioural Analysis of Drug Dependence. Academic Press, New York 1986
  • Golden J. S., et al. Problems in the distortion in doctor-patient communications. Psychiatry Med. 1970; 1: 127–149
  • Goldman R., et al. Marketing “Mind Mechanics”: Decoding antidepressant drug advertisements. Soc. Sci. Med. 1986; 22: 1047–1058
  • Golombok S. The contribution of psychology to understanding long-term tranquillizer use. Understanding Tranquillizer Use—The Role of the Social Sciences, J. Gabe. Tavistock/Routledge, London 1991; 15–30
  • Golombok S., et al. Cognitive impairment in long-term benzodiazepine users. Psychol. Med. 1988; 18: 365–374
  • Goodman Gilman A., et al. The Pharmacological Basis of Therapeutics. Macmillan, New York 1985
  • Gravenstein J. S., et al. Effect of antitussive agents on experimental and pathological cough in man. J. Applied Physiol. 1954; 7: 119–139
  • Green L. W., et al. Development of randomized patient education experiments with urban poor hypertensives. Patient Couns. Health Educ. Winter/Spring, 1979; 106–111
  • Greenberg R. N. Overview of patient compliance with medication dosage: A literature review. Clin. Ther. 1984; 6: 592–599
  • Greenblatt D. J., et al. Benzodiazepine in Oinical Practice. Raven Press, New York 1974
  • Greenfield S., et al. Expanding patient involvement in care. Ann. Intern. Med. 1985; 102: 520–528
  • Greenhalgh T. Drug prescribing and self-medication in India: An exploratory survey. Soc. Sci. Med. 1987; 25: 307–318
  • Grof C, et al. The Stormy Search for the Self. Tarcher Inc, Los Angeles 1990
  • Grunbaum A. Explication and implications of the placebo concept. Placebo—Theory, Research and Mechanisms, L. White, et al. Guilford Press, New York 1985; 9–36
  • Gryfe-Becker B. M., et al. Effect of auxiliary prescription labels on the elderly ambulatory patient's drug knowledge. Drug Intell. Clin. Pharm. 1989; 23: 324–329
  • Haayer F. M. Rational prescribing and sources of information. Soc. Sci. Med. 1982; 16: 2017–2023
  • Hall D. Prescribing as social exchange. Prescribing Practice and Drug Usage, R. Mapes. Croom Helm, London 1980; 39–57
  • Hall J. A., et al. Meta-analysis of correlates of provider behavior in medical encounters. Med. Care 1988; 26: 657–672
  • Hamilton J. A. Cognitive-mediated and socio-environmental effects in pharmacology: Beyond placebo controls. Soc. Pharmacol. 1987; 1: 305–322
  • Hampton R. J. An analysis of the relationship between variations in promotion and sales of ethical pharmaceutical products. Ph.D. thesis, University of Wisconsin, Wisconsin 1961
  • Hardon A. P. The use of modern pharmaceuticals in a Filipino village: Doctor's prescription and selfmedication. Soc. Sci. Med. 1987; 25: 277–292
  • Harre R. Making social psychology scientific. The Development of Social Psychology, R. Gilmour, S. Duck. Academic Press, London 1980; 27–51
  • Harrell G. D., et al. An evaluation of the expectancy value model of attitude measurement for physician prescribing behaviour. J. Mark. Res. 1974; 11: 269–278
  • Harris C. M., et al. Prescribing—A Suitable Case for Treatment. The Royal College of General Practitioners, Occasional paper 24. London 1984
  • Harris R., et al. Health beliefs, compliance, and control of diabetes mellitus. South. Med. J. 1985; 2: 162–166
  • Hartog R. Essential and non-essential drugs marketed by the 20 largest European Pharmaceutical Companies in developing countries. Soc. Sci. Med. 1993; 37: 897–904
  • Harvey J. L., et al. Comparative attitudes to verbal and written medication information among hospital outpatients. DICP Ann. Pharmacother. 1991; 25: 925–928
  • Hayes-Bautista D. E. Modifying the treatment: Patient compliance, patient control and medical care. Soc. Sci. Med. 1976; 10: 233–238
  • Haynes R. B. Patient compliance then and now. Patient Educ. Couns. 1987; 10: 103–106
  • Haynes R. B., et al. Improvements of medication compliance in uncontrolled hypertension. Lancet 1976; 1: 1265–1268
  • Compliance in Health Care, R. B. Haynes, et al. John Hopkins University Press, Baltimore, MD 1979
  • Haynes R. B., et al. A critical review of interventions to improve compliance with prescribed medications. Patient Educ. Counsel 1987; 10: 155–168
  • Hecht A. B. Improving medication compliance by teaching outpatients. Nur. Forum 1974; 13: 113–129
  • Heiman E. M., et al. Patient characteristics and clinician attitudes influencing the prescribing of bensodiazepines. J. Clin. Psychiatry 1981; 42: 71–73
  • Helgesen G., et al. Drug information and remote customers in a rural Norwegian pharmacy. J. Soc. Adm. Pharm. 1983; 1: 49–57
  • Helman C. G. “Tonic,” “fuel” and “food”: Social and symbolic aspects of the long-term use of psychotropic drugs. Soc. Sci. Med. 1981a; 15B: 521–533
  • Helman C. G. Patients' perceptions of psychotropic drugs. J. Roy. Coll. Gen Pract. 1981b; 31: 107–112
  • Hemminki E., et al. The quality of drug advertisements in the Finnish medical journals. Soc. Sci. Med. 1973; 7: 51–59
  • Hemminki E. The effect of a doctor's personal characteristics and working circumstances on the prescribing of psychotropic drugs. Med. Care 1974a; 12: 351–357
  • Hemminki E. General practitioners' indications for psychotropic drugs. Scand. J. Soc. Med. 1974b; 2: 79–85
  • Hemminki E. Review of the literature on the factors affecting drug prescribing. Soc. Sci. Med. 1975; 9: 111–115
  • Hemminki E. Polypharmacy among psychiatric patients. Acta Psychiatr. Scand. 1977; 56: 347–356
  • Henderson M. A. Tuberculosis in developing country: Experiences of the TB services at BMH, Dharan. J. R. Army Med. Corp. 1984; 130: 22–30
  • Hepler C. D., et al. Rationales expressed by empiric antibiotic prescribes. Am. J. Hosp. Pharm. 1982; 39: 1647–1655
  • Herman C. M., et al. Communicating drug information to physicians. J. Med. Educ. 1976; 51: 189–196
  • Herxheimer A., et al. Minimum information needed by prescribes. Br. Med. J. 1978; 2: 1129–1132
  • Heszen-Klemens I., et al. Doctor-patient interaction, patients' health behaviour and effects of treatment. Soc. Sci. Med. 1984; 19: 9–18
  • Heurtin-Roberts S. Health beliefs, compliance-Hypertension. JAMA 1990; 264: 2864
  • Higgitt A., et al. Group treatment of benzodiazepine dependence. Br. J. Addict. 1987; 82: 517–532
  • Hindmarch I. Psychomotor function and psychoactive drugs. Br. J. Clin. Pharmacol. 1980; 10: 189–209
  • Das Placebo-Problem, H. Hippius, et al. Fischer Verlag, Stuttgart 1986
  • Hjelle L. A., et al. Personality Theories. McGraw-Hill, New York 1985
  • HMS. Report of the Committee of Enquiry into the Relationship of the Pharmaceutical Industry with the NHS 1965–1967, Appendix 2. London 1967
  • Hoffman R. G., et al. Self-concept changes in diabetic adolescents. Pediatr. Adolesc. Endocrinol. 1982; 10: 32–38
  • Hogerzeil H. V. Standardised Supply of Essential Drugs in Ghana. University of Utrecht, Utrecht 1974
  • Hohmann A. A., et al. Psychotropic prescriptions in US ambulatory medical care. DICP 1991; 25: 85–89
  • Hollister L. E., et al. Long-term use of diazepam. JAMA 1981; 246: 1568–1570
  • Holm M. Intervention against long-term use of hypnotic/sedatives in general practice. Scand. J. Prim. Health Care 1990; 8: 113–117
  • Holm M. Patienters holdning til langtidsbrug af benzodiazepiner [Patients' opinions about long-term use of benzodiazepines]. Ugeskr. Laeger 1991; 153: 1933–1936
  • Holt G. A., et al. Patient interpretation of label instructions. Am. Pharm. 1992; NS32: 242–246
  • Hounsa A. M., et al. An application of Ajzen's theory of planned behaviour to predict mothers' intention to use oral rehydration therapy in rual area of Benin. Soc. Sci. Med. 1993; 37: 253–261
  • Hughes R., et al. The Tranquilizing of America: Pill Popping and the American Way of Life. Harcourt Brace Jovanovich, New York 1979
  • Hulka B. S., et al. Doctor-patient communication and outcomes among diabetic patients. J. Commun. Health 1975a; 1: 15–26
  • Hulka B. S., et al. Medication use and misuse: Physician-patient discrepancies. J. Chronic Dis. 1975b; 2: 7–21
  • Huttunen M. O. On the ethics of the clinical use of neuroleptics. Psychiatr. Fenn. 1992; 23: 53–61
  • Isenalumbe A. E., et al. Polypharmacy: Its cost burden and barrier to medical care in drug oriented health care system. Int. J. Health Serv. 1988; 18: 335–342
  • Jacobs C, et al. Behaviour of cancer patients: A randomized study of the effects of education and peer support groups. Am. J. Clin. Oncol. (CCT) 1983; 6: 347–350
  • Jerome J., et al. The Lost Years—Tranquilisers and After. The Effect Minor Tranquillisers Can Have on Our Life and Our Families. Virgin 1991
  • Johnson L. K. C, et al. Sedative-hypnotics and human performance. Psychopharmacology 1982; 76: 101–113
  • Johnson J. F., et al. A concurrent quality assurance review of psychotropic prescribing in elderly patients: Process and outcome measures. J. Geriatr. Drug Ther. 1990; 4(4)43–61
  • Johnstone E. C, et al. Further investigation of the predictors of outcome following first schizophrenic episodes. Br. J. Psychiatry 1990; 157: 182–190
  • Jospe M. The Placebo Effect. Lexington Books, Lexington, MA 1976
  • Joubert P. W. T., et al. Patient package inserts. Nature, notions and needs. Clin. Pharmacol. Ther. 1975; 18: 507–513
  • Joyce C. R. B., et al. Quantitative study of doctor-patient communication. Q. J. Med. New Series 1969; 38: 183–194
  • Juergens S. Alprozalam and diazepam: Addiction potential. J. Subst. Abuse Treat. 1991; 8: 43–51
  • Kane R. L., et al. Problems in patient-doctor communications. Med. Care 1967; 5: 260–271
  • Kanji N., et al. Drugs Policy in Developing Countries. Zed Books, London 1992
  • Kaplan K. H. Law, ethics and psychiatry in the general hospital: Assessing judgment. Gen. Hosp. Psychiatry 1988; 9: 202–208
  • Kaufmann C. L. Informed consent and patient decision making: Two decades of research. Soc. Sci. Med. 1983; 21: 1657–1664
  • Kelly G. R., et al. Utility of the health belief model in examining medication compliance among psychiatric outpatients. Soc. Sci. Med. 1987; 25: 1205–1211
  • Kimberlin C, et al. A comparison of patient education methods used in community pharmacies. J. Pharm. Mark. Management 1987; 1: 75–94
  • Kirscht J. P., et al. Patient adherence to antihypertensive medical regimens. J. Commun. Health 1977; 3: 115–124
  • Klaukka T., et al. Lääkarien saama lääkeinformatio. [The drug information that the physicians receive]. Suom. Lääkarilehti 1975; 30: 494–499
  • Knudsen H. Informasjon i apotek [Information in pharmacies]. Norsk Farm. Tidsk. 1979; 87: 120–125
  • Knudsen-Stromme H., et al. Physicians' perceived drug-related problems and preventive strategies concerning old patients in general practice. J. Soc. Adm. Pharm. 1992a; 9: 172–178
  • Knudsen-Stromme H., et al. Factors related to the choice of antihypertensive and hypnotic drug treatment in old patients. Scand. J. Prim. Health Care 1992b; 10: 301–305
  • Koestenbaum P. Min syn på livet och döden [Is There an Answer to Death). Svenska Dagbladets Förlag, Stockholm 1984
  • Korhonen T., et al. A controlled trial on the effects of patient education in the treatment of insulin-dependent diabetes. Diabetes Care 1983; 6: 256–261
  • Kristensen P., et al. Benzodiazepiner—Holdninger og forskrivningspraksis blant allmenpraktikere og psykiatere [Benzodiazepines—Opinion and prescribing practice among GPs and psychiatrists]. Tidskr. Nor. Laegeforen. 1991; 111: 2241–2245
  • Krupka L. R., et al. Prescribing drug advertising: Trends and implications. Soc. Sci. Med. 1985; 20: 191–197
  • Lader M., et al. The biological basis of benzodiazepine dependence. Psychol. Med. 1987; 17: 539–547
  • Lader M. History of benzodiazepine dependence. J. Subst. Abuse Treat. 1991; 8: 53–59
  • Landahl S., et al. Digitalis therapy in a 70 year-old population. Acta Med. Scand. 1977; 202: 437–443
  • Lapp J. E., et al. Effect of patient demand for drugs on physician prescribing. Int. J. Psychiatry Med. 1983–84; 13: 193–205
  • Larsson S. Identitet och beroende—En förstudie om beroende av lugnande medel [Identity and Addiction—A Study of Benzodiazepine Dependence]. Sober, Stockholm 1992
  • Larsson S., et al. Allmänhetens och läkarnas uppfattningar om psykofarmakafbrskrivningen [The general public's and physician's opinions about psychotropic prescribing]. Sv. Farm Tidskr. 1992; 96(2)33–37
  • Larsson S., et al. A Cognitive Perspective on the Treatment of Clients who Suffer from Dependency Caused by Benzodiazepines. J. Soc. Adm. Pharm. Kilen, Stockholm 1994
  • Larsson S., et al. The cognitive effects of a continuing education course about sleeping disorders for physicians and nurses, in press.
  • Latiolais C. J., et al. Misuse of prescription medications by outpatients. Drug. Int. Clin. Pharm. 1969; 3: 270–277
  • Leary J. A., et al. Self-administered medications. Am. J. Nurs. 1971; 71: 1193–1194
  • Lee P. R., et al. Drug promotion and labeling in developing countries: An update. J. Clin. Epidemiol. 1991; 44: 49S–55S, Suppl. II
  • Leventahl H., et al. Behavioural theories and the problem of compliance. Patient Educ. Counsel. 1987; 10: 117–138
  • Levinson D. J., et al. Becoming a patient. Arch. Gen. Psychiatry 1967; 17: 385–406
  • Lexchin J. Doctors and retailers: Therapeutic education or pharmaceutical promotion. Int. J. Health Serv. 1989; 19: 663–679
  • Ley P. Primacy, rated importance and the recall of medical statements. J. Health Behav. 1972; 13: 311–317
  • Ley P. Psychological studies of doctor-patient communication. Contribution to Medical Psychology, S. Rachman. Pergamon Press, Oxford 1977; 9–42
  • Ley P., et al. Communicating with the Patient. Staples Press, London 1967
  • Lilja J. How physicians choose their drugs. Soc. Sci. Med. 1976; 10: 363–365
  • Lilia J. Users of disulfiram (Antabuse) in Uppsala, Sweden. Soc. Pharmacol. 1988; 2: 205–228
  • Lilja J., et al. The mental mirrors of pharmacists: How do pharmacists perceive their OTC customers?. Int. J. Pharm. Pract. 1993; 2: 136–141
  • Lima J., et al. Compliance with short-term antimicrobial therapy: Some techniques that help. Pediatrics 1976; 57: 383–386
  • Linde V., et al. The patient—An obstacle to or a means for pharmaceutical marketing success. EPHMRA/ESOMAR: Researching opportunities and limitations for health-care marketing. Conf. Proceedings. Neu Isenberg, 1989; 89–110
  • Linn L. S. Physician characteristics and attitudes toward legitimate use of psychotropic drugs. J. Health Soc. Behav. 1971; 12: 132–140
  • LinnÉ C. Hinder för läkekonsten. [Barriers to the Art of Medicine]. Originally published in 1752. Sv. Linné Sällskapet, Ekenäs 1948
  • Lipman R. S., et al. Medication attitudes and drug response. Dis. Nerv. Syst. 1969; 30: 453–459
  • Lisi D. M., et al. Instructions provided for proper use of nonprescription ophthalmic drops. Am. J. Hosp. Pharm. 1991; 48: 987–988
  • Locker D. Symptoms and Illness—The Cognitive Organization of Disorder. Tavistock, London 1979
  • Lowinger, et al. What makes the placebo work?. Arch. Gen. Psychiatry 1969; 20: 84–88
  • Lucki C, et al. Chronic use of benzodiazepines and psychomotor test performance. Psychopharmacology 1986; 88: 426–433
  • Mackowiak J. I., et al. Effects of promotion on pharmaceutical demand. Soc. Sci. Med. 1985; 20: 1191–1197
  • Madden E. E. Evaluation of outpatient pharmacy patient counseling. J. Am. Pharm. Assoc. 1973; NS13: 437–443
  • Magnusson D., . An interactional perspective for human development. Human Development—An Interactional Perspective, D. Magnusson, V. L. Allen, et al. Academic Press, New York 1983; 3–31
  • Maiman L. A., et al. Education for self-treatment by adult asthmatics. JAMA 1979; 251: 1919–1922
  • Malahy B. The effect of instruction and labeling on the number of medication errors made by patients at home. Am. J. Hosp. Pharm. 1966; 23: 283–292
  • Mallet L., et al. Readability evaluation of nine patient drug education sources. Am. Pharm. 1988; NS28(11)33–36
  • Manheimer D. I., et al. Popular attitudes and beliefs about tranquilizers. Am. J. Psychiatry 1973; 130: 1246–1253
  • Manning P. R., et al. How internists learned about Cemetidine. Ann. Intern. Med. 1980; 92: 690–692
  • Mant A., et al. The path to prescription: Sex differences in psychotropic prescribing for general practice patients. Soc. Psychiatry 1983; 18: 185–192
  • Mant A., et al. Development of long term use of psychoropic drugs by general practice patients. Br. Med. J. 1988; 1: 251–254
  • Mapes R., et al. Aspects of British general practitioners' prescribing. Med. Care 1977; 15: 371–381
  • Marion R. J., et al. Training asthmatic children to use their nebulizer correctly. J. Asthma 1983; 20: 183–188
  • Marks J., et al. The hospital patient and his knowledge of the drugs he is receiving. Int. Nurs. Rev. 1972; 19: 39–51
  • Marks J. Diazepines— Use, Overuse, Misuse, Abuse. MTP Press, Lancaster 1985a
  • Marks J. Chronic anxiolytic treatment: Benifit and risk. Adv. Biochem. Psychopharmacol. 1985b; 40: 173–183
  • Marlatt G. A., . Alcoholism drug dependence: Cognitive social learning factors in addictive behaviors. Behaviour Modification: Principles, Issues, Applications, A. E. Craighead, et al. Houghton Mifflin, Boston 1981
  • Marlatt G. A., . Alcohol, the magic elixir: Stress, expectancy and the transformation of emotional states. Stress and Addiction, E. Gottheil, et al. Brunner/Mazel, New York 1987
  • Maronde R. F., et al. Physician prescribing practices—A computer based study. Am. J. Hosp. Pharm. 1969; 26: 566–573
  • Marsh P., et al. The Rules of Disorder. Routledge & Kegan Paul, London 1978
  • Martin J. P. Social Aspects of Prescribing. W. Heineman, London 1967
  • Marvola M., et al. Customer enquiries in Finnish pharmacies. Acta Pharm. Fenn. 1978; 87: 95–103
  • Mason H. L., et al. Medication counseling behaviours and attitudes of rural community pharmacists. DICP 1984; 18: 409–414
  • Mattar M. E., et al. Pharmaceutic factors affecting pediatric compliance. Pediatrics 1975; 55: 1010–1018
  • Matty P. J., et al. Out-patient use of beta-blocking agents—Prescribing preferences of physicians in training. J. Clin. Pharm. Ther. 1987; 12: 409–414
  • Mazis M., et al. Patient attitudes about two forms of printed oral contraceptive information. Med. Care 1978; 16: 1045–1054
  • Mazzuca S. A. Does patient education in chronic disease have therapeutic value?. J. Chronic Dis. 1982; 35: 521–529
  • Mazzuca S. A., et al. The diabetes education study: A controlled trial of the effects of diabetes patient education. Diabetes Care 1986; 9: 1–10
  • Mazzullo J. M., et al. Variations in the interpretation of prescription instructions. JAMA 1974; 111: 929–931
  • McCaul K. D., et al. Diabetes regimen behaviours: Predicting adherence. Med. Care 1987; 25: 868–881
  • McClellan T. A., et al. Use of antipsychotic and antidepressant drugs by chronically ill patients. Am. J. Psychiatry 1970; 126: 1771–1773
  • McIntosh J. Process of communication, information seeking and control associated with cancer. Soc. Sci. Med. 1974; 8: 167–187
  • McKenzie J. General practitioners' prescription decisions. Soc. Econ. Adm. 1968; 2: 159–167
  • McLaren S., et al. A study of psychotropic medication given “as required” in a regional secure unit. Br. J. Psychiatry 1990; 156: 732–735
  • McMahon T., et al. Who provides patients with drug information?. Br. Med. J. 1987; 1: 355–356
  • McNair D. M. Antianxiety drugs and human performance. Arch. Gen. Psychiatry 1973; 29: 611–617
  • Meade T. W. Prescribing chloramphenicol in general practice. Br. Med. J. 1967; 1: 671–674
  • Meade V. APhA survey looks at patient counseling. Am. Pharm. 1992; NS32: 307–309
  • Medawar C. Power and Dependence. Social Audit, London 1992
  • Mehya K. K., et al. Prescription drug advertising trends: A study of oral hypoclycemics. Soc. Sci. Med. 1989; 29: 853–859
  • Melrose D. Bitter Pills. OXFAM, London 1982
  • Melville K. A. The influence of general practitioners' attitudes on their prescribing. Research in Psychology and Medicine, DJ. Oborne, MM. Gruneberg, JR. Eiser. Academic Press, London 1979; 179–186
  • Melville K. A., . Anatomy of a disaster: The case of Practolol. Prescribing Practice and Drug Usage, R. Mapes, et al. Croom Helm, London 1980; 121–144
  • Mester R. Psychiatrists' reactions to their patients' refusal of drugs. Isr. Ann. Psychiatry 1972; 10: 373–381
  • Metzner R. States of consciousness and transpersonal psychology. Existential-Phenomenological Perspectives in Psychology, RS. Valle, et al. Plenum Press, New York 1989; 329–338
  • Meyer D., et al. Common-sense models of illness: The example of hypertension. Health Psychol. 1985; 4: 115–135
  • Miller E. Benzodiazepine and the behaviour therapist: Managing withdrawal and the problems of concurrent treatment with these drugs. Behav. Psychother. 1986; 14: 1–12
  • Miller S. P., et al. Regimen compliance two years after myocardial infarction. Nurs. Res. 1990; 39: 333–336
  • Miller S. P., et al. Fishbein's model of reasoned action and compliance behaviour of hypertensive patients. Nurs. Res. 1992; 41: 104–109
  • Milliren J. W. Some contingencies affecting the utilization of tranquilizers in long-term care of the elderly. J. Health Soc. Behav. 1977; 18: 206–211
  • Montagne M. The culture of long-term tranquilliser users. Understanding Tranquillizer Use—The Role of the Social Sciences, J. Gabe. Tavistock/Routledge, London 1991; 48–68
  • Moore S. R. Cognitive variants in the elderly: An integral part of medication counseling. DICP 1983a; 17: 840–842
  • Moore S. R., et al. Receipt of prescription drug information by the elderly. DICP 1983b; 17: 920–923
  • Morabia A., et al. The influence of patient and physician gender on prescription of psychotropic drugs. J. Clin. Epidemiol. 1992; 45: 111–116
  • Morgan R., et al. Psycotropic drugs: Another survey of prescribing patterns. Br. J. Psychiatry 1984; 144: 298–302
  • Morris L. A., et al. A survey of the effects of oral contraceptive patient information. JAMA 1977; 238: 2504–2508
  • Morris L. A., et al. Effects of written drug information on patient knowledge and compliance: A literature review. Am. J. Public Health 1979; 69: 47–52
  • Morris L. A., et al. Application of the readability concept to patient-oriented drug information. Am. J. Hosp. Pharm. 1980; 37: 1504–1509
  • Morris L. A., et al. A survey of patients, receipt of prescription drug information. Med. Care 1982; 20: 596–605
  • Morris L. A., et al. A survey of patient sources of prescription drug information. Am. J. Public Health 1984; 74: 1161–1162
  • Morris L. A., et al. Consumer attitudes about advertisements for medicinal drugs. Soc. Sci. Med. 1086; 22: 629–638
  • Morris L. A., et al. A segmentational analysis of prescription drug information seeking. Med. Care 1987; 25: 953–964
  • Mull J. D., et al. Culture and compliance: Among leprosy patients in Pakistan. Soc. Sci. Med. 1989; 29: 798–811
  • Murray J. Long-term psychotropic drug taking and the process of withdrawal. Psych. Med. 1981; 11: 853–858
  • Nash E. H., et al. Systematic preparation of patients for short-term psychotherapy. J. Nerv. Ment. Dis. 1965; 140: 374–383
  • Nelson E. C, et al. Impact of patient perceptions on compliance with treatment for hypertension. Med. Care 1978; 16: 893–906
  • Newcomer D. R., et al. Effectiveness of a combined self-adminsitered and patient teaching program. DICP 1974; 8: 374–381
  • Nisbett R., et al. Telling more than we know: Verbal reports on mental processes. Psychol. Rev. 1977; 84: 231–279
  • Nisbett R., et al. Human Inference: Strategies and Shortcomings of Social Judgements. Prentice-Hall, Englewood Cliffs, NJ 1980
  • Noh S., et al. Living with psychiatric patients: Implications for the mental health of family members. Soc. Sci. Med. 1987; 25: 263–271
  • Norell S. E. Monitoring compliance with pilocarpine therapy. Am. J. Ophthalmol. 1981; 92: 727–731
  • Norman G. R., et al. Measuring physician's performances by using simulated patients. J. Med. Educ. 1985; 60: 925–934
  • Olofson M., et al. Trends in the prescription of antidepressants by office-based psychiatrists. Am. J. Psychiatry 1993; 150: 571–577
  • Olowu A. A., et al. Compliance and drug use: Some Nigerian data. J. Soc. Adm. Pharm. 1986; 3: 157–159
  • Ordonez-Plaja A., et al. Communications between physicians and patients in outpatient clinics. Milb. Mem. Fund. Q. 1968; 56: 161–213
  • Ort R. S., et al. The doctor-patient relationship as described by physicians and medical students. J. Health Hum. Behav. 1964; 5: 25–34
  • Osiobe S. A. Use of information resources by health professionals: A review of the literature. Soc. Sci. Med. 1985; 21: 965–973
  • Oswald I., et al. Benzodiazepine hypnotics remain effective for 24 weeks. Br. Med. J. 1982; 284: 860–863
  • Overgaard-Larsen B., et al. The active medicine user. Scand. J. Prim. Health Care 1985; 3: 55–59
  • Pakenham K. I., et al. Family care and schizophrenia: The effects of a supportive educational program on relatives' personal and social adjustment. Austr. NZ J. Psychiatry 1987; 21: 580–590
  • Parker W. A. Effect of hospitalization on patient use of hypnotics. Am. J. Hosp. Pharm. 1983; 40: 446–447
  • Parkin D. M., et al. Deviation from prescribed drug treatment after discharge from hospital. Br. Med. J. 1976; 2: 686–688
  • Perry H. J., et al. National pattern of psychotherapeutic drug use. Arch. Gen. Psychiatry 1973; 28: 769–783
  • Patton M. Q. Qualitative Evaluation Methods. Sage, Beverly Hills, CA 1983
  • Patton M. Q. Qualitative Evaluation and Research Methods2nd ed. Sage, London 1990
  • Paul G. L. Can pregnancy be a placebo effect? Terminology, designs and conclusions in the study of psychosocial and pharmacological treatments of behavioral disorders. Placebo—Theory, Research and Mechanisms, L. White, et al. Guilford Press, New York 1985; 137–163
  • Payer L. Medicine and Culture—Varieties of Treatment in the United States, England, West Germany and France. Holt, New York 1988
  • Peay M. Y., et al. Differences among practitioners in patterns of preferences for information sources in the adoption of new drugs. Soc. Sci. Med. 1984; 18: 1019–1025
  • Peay M. Y., et al. Patterns of preference for information sources in the adoption of new drugs by specialists. Soc. Sci. Med. 1990; 31: 467–476
  • Pepper O. H. P. A note on placebo. Am. J. Pharm. 1945; 117: 409–412
  • Peterson O. L., et al. An analytic study of North Carolina general practice 1953. J. Med. Educ. 1956; 31: 165
  • Petursson H., et al. Psychometric performance during withdrawal from long-term benzodiazepine treatment. Psychopharmacology 1983; 81: 345–349
  • Pinsker H., et al. Use of benzodiazepines in primary-care geriatric patients. J. Am. Geriatr. Soc. 1984; 32: 595–597
  • Plotkin W. B. A psychological approach to placebo. Placebo—Theory, Research and Mechanisms, L. White, et al. Guilford Press, New York 1985; 237–254
  • Plumridge R. J. Improving patient care and pharmacy management: The effect of hospital formularies. Drug. Int. Clin. Pharm. 1984; 18: 652–656
  • Plumridge R. J., et al. Drug bulletins: Effectiveness in modifying prescribing and methods of improving impact. DICP 1989; 23: 330–333
  • Podell R. N., et al. Patient psychological defenses and physician response in long-term treatment of hypertension. J. Fam. Pract. 1976; 3: 145–149
  • Polkinghorne D. E. Phenomenological research methods. Existential-Phenomenological Perspectives in Psychology, R. S. Valle, et al. Plenum Press, New York 1989; 41–60
  • Popper K. R. Objective Knowledge—An Evolutionary Approach. Clarendon Press, Oxford 1975
  • Popper K. R. The Self and Its Brain—An Argument for Interactionism. Springer Int, New York 1977
  • Porter A. M. W. Drug defaulting in a general practice. Br. Med. J. 1969; 1: 218–222
  • Pratt L. How do patients learn about disease?. Soc. Prob. 1956; 4: 29–40
  • Rabkin J. G., et al. Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression. Am. J. Psychiatry 1990; 147: 1622–1626
  • Rantucci M. J., et al. Over the counter medication. J. Soc. Adm. Pharm. 1986; 3: 81–91
  • Rawlins M. C. Truth-telling and paternalism in the clinic: Philosphical reflections on the use of placebos in medical practice. Placebo—Theory, Research and Mechanisms, L. White, et al. Guilford Press, New York 1985; 403–418
  • Ray W. A., et al. Improving antibiotic prescribing in outpatient practice. Med. Care 1985; 23: 1307–1313
  • Ray W. A., et al. Reducing long-term Diazepam prescribing in office practice. JAMA 1986; 256: 2536–2539
  • Raynes N. V. Factors affecting the prescribing of psychotropic drugs in general practice consultations. Psychol. Med. 1979; 9: 671–679
  • Raynor D. K. Patient compliance: The pharmacist's role. Int. J. Pharm. Pract. 1992; 1: 126–135
  • Raynor D. K., et al. Patient non-comprehension of labelled instructions. Pharm. J. 1982; 229: 648–649
  • Rees J. A., et al. Difficulties in the use of medicine packaging. Int. J. Pharm. Pract. 1992; 1: 160–163
  • Rehder T. L., et al. Improving medication compliance by counseling and special prescription container. Am. J. Hosp. Pharm. 1980; 37: 379–385
  • Renaud M., et al. Practice setting and prescribing profiles: The simulation of tension headaches to general practitioners working in different practice settings in the Montreal area. Am. J. Public Health, 70: 1068–1973
  • Renton C. A., et al. A follow-up of schizophrenic patients in Edinburgh. Acta Psychiatr. Scand. 1963; 39: 548–601
  • Richards A. D. Attitude and drug acceptance. Br. J. Psychiatry 1964; 110: 46–52
  • Rickels K. Are bensodiazepines overused and abused?. Br. J. Clin. Pharm. 1981; 11: 71S–83S
  • Rickels K. Antianxiety therapy: Potential value of long-term treatment. J. Clin. Psychiatry 1987; 48: 7–11, Suppl 12
  • Rickels K., et al. Drug and placebo treatment of manifest anxiety, clinical improvements, and side reactions. Arch. Gen. Psychiatry 1967; 16: 369–372
  • Rickels K., et al. Assessment of dosage devation in outpatient drug research. J. Clin. Pharmacol. 1970; 10: 153–160
  • Rickels K., et al. Long-term diazepam therapy and clinical outcome. JAMA 1983; 250(6)767–771
  • Ridley H. Drugs of Choice. Social Audit, London 1985
  • Ried L. D., et al. Medical and psychosocial factors predictive of psychotropic drug use in elderly patients. Am. J. Public Health 1990; 80: 1349–1353
  • Riska E., et al. Advertising for psychotropic drugs in the Nordic countries: Metaphores, gender and the life situations. Soc. Sci. Med. 1991; 32: 465–471
  • Riska E., . Use of minor tranquillizers. Minor Tranquillizers in the Nordic Countries, E. Riska, et al. Nordic Council for Alcohol and Drug Research, Helsinki 1993; 45–67
  • Robinson D., et al. Self-Help and Health—Mutual Aid for Modem Problems. Robinson, London 1977
  • Robinson E. J., et al. Improving the efficiency of patients' comprehension monitoring: A way of increasing patients' participation in general practice consultations. Soc. Sci. Med. 1985; 21: 915–919
  • Rosenstock I. M. Why people use health services. Milb. Mem. Fund. Q. 1966; 44: 94–127
  • Ross L. The intuitive psychologist and his shortcomings: Distortions in the attribution process. Cognitive Theories in Social Psychology., L. Berkowitz. Academic Press, New York 1978; 337–384
  • Ross S., . Placebo agentry: Assessment of drug and placebo effects. Placebo—Theory, Research and Mechanisms, L. White, et al. Guilford Press, New York 1985; 67–82
  • Ross E. L. The Psychobiology of Mind-Body Healing. Norton, New York 1988
  • Roth H. P. Measurement of compliance. Pat. Educ. Counsel. 1987; 10: 107–116
  • Roth H. P., et al. Measuring intake of a prescribed medication: A bottle count and a tracer technique compared. Clin. Pharmacol. Ther. 1970; 11: 228–237
  • Rovelli M. R. Noncompliance in organ transplant recipients. Transpl. Proc. 1989; 21: 833–834
  • Rubin R. R., et al. Effect of diabetes education on self-care, metabolic control and emotional well-being. Diabetes Care 1989; 12: 673–679
  • Rubinstein B. B. Psychoanalytical hypothesis and the problem of their confirmation. Theories of the Unconscious and Theories of the Self., R. Stern. Analytic Press, Hillsdale, NJ 1987
  • Rudd P., et al. Issues in patient compliance: The search for therapeutic sufficiency. Cardiology 1992; 80: 2–10, Suppl 1
  • Rudestam K. E., et al. The clinical judgement process in the prescribing of psychotropic drugs. Int. J. Addict. 1981; 16: 1049–1070
  • Sackett D. L., et al. Randomized clinical trial of strategies for improving medical compliance in primary hypertension. Lancet 1975; 1: 1205–1207
  • Safran J. D., . Affect and the unconscious: A cognitive perspective. Theories of the Unconscious and Theories of the Self, R. Stern, et al. Analytic Press, Hillsdale, NJ 1987; 191–212
  • Sandler D. A., et al. Is an information booklet for patients leaving hospital helpful and useful?. Br. Med. J. 1989; 1: 870–874
  • Srariff A., et al. A study of the patient's self-interpretation of prescription instructions. J. Clin. Pharm. Ther. 1992; 17: 125–128
  • Sauer K. A., et al. The relationship between the health beliefs and compliance in a clinical trial. J. Soc. Adm. Pharm. 1987; 4: 41–50
  • Schachter S. The interaction of cognitive and physiological determinants of emotional state. Cognitive Theories in Social Psychology, L. Berkowitz. Academic Press, New York 1978
  • Schou M. No help from lithium? About patients who might have been but were not helped by prophylactic lithium treatment. Compr. Psychiatry 1988; 29: 83–90
  • Schulman B. A. Active patient orientation and outcomes in hypertensive treatment. Med. Care 1979; 17: 267–280
  • Schwartz D. R. N., et al. Medication errors made by the elderly, chronically ill patients. Ann. J. Public Health 1962; 52: 2018–2029
  • Schwartz H. I., et al. Autonomy and the right to refuse treatment: Patients' attitudes after involuntary medication. Hasp. Commun. Psychiatry 1988; 39: 1049–1106
  • Scocozza L. Ethics and medical science. On voluntary participation in biomedical experimentation. Acta Sociol. 1989; 32: 283–293
  • Scott D. M., et al. Medication fees and their impact on prescribing habits for the nearpoor. J. Pharmacoepidemiol. 1990; 1(1)23–33
  • Sczupak C. A., et al. Relationship between patient-oriented pharmaceutical service and therapeutic outcomes of ambulatory patients in diabetes mellitus. Am. J. Hosp. Pharm. 1977; 34: 1238–1242
  • Secherist K. R. The effect of repetitive teaching on patient's knowledge about drugs to be taken at home. Int. J. Nurs. Stud. 1979; 16: 51–58
  • Segal A. Patient evaluation of physician role performance. Soc. Sci. Med. 1980; 14A: 269–278
  • Segal R., et al. Prescribers' beliefs and values as predictors of drug choice behaviour. Am. J. Hosp. Pharm. 1982; 39: 1891–1897
  • Segal R., et al. Drug choice as problem solving process. Med. Care 1985; 23: 967–977
  • Self T. H., et al. The value of demonstration and the role of pharmacist in teaching the correct use of pressurized bronchodilators. Can. Med. Assoc. J. 1983; 128: 129–131
  • Seltzer A., et al. Effect of patient education on medical compliance. Can. J. Psychiatry 1980; 25: 638–645
  • Semla T. P., et al. Perceived purpose of prescription drugs: The Iowa 65+ rural health study. DICP Ann. Pharmacother. 1991; 25: 410–413
  • Shapiro A. K. Attitudes toward the use of placebos in treatment. J. Nerv. Ment. Dis. 1970; 130: 200–211
  • Shapiro A. K., et al. Diazepam: How much better than placebo?. J. Psychiatr. Res. 1983; 17: 51–73
  • Shaugnessy A. F. Patients' understanding of selected pharmacy terms. Am. Pharm. 1988; NS28(10)38–42
  • Shiell A. Long-term tranquilizer use: The contribution of health economics. Understanding Tranquillizer Use, J. Gabe. Tavistock/Routledge, London 1991; 92–111
  • Shorr R. I., et al. Failure to limit quantities of benzodiazepines hypnotic drugs for outpatients: Placing the elderly at risk. Am. J. Med. 1990; 89: 725–732
  • Simons H. W. Distinguishing the rhetorical from the real: The case of psychotherapeutic placebos. Rhetoric in the Human Sciences, H. W. Simon. Sage, London 1989
  • Siwers A. Benzodiazepines in the treatment of anxiety. Pharmacological Treatment of Anxiety. National Board of Health and Welfare Drug Committee, Uppsala 1988; 95–100
  • Sjoberg G., et al. A Methodology for Social Research. Harper & Row, New York 1968
  • Slatter S. L. Competition and Marketing in the Pharmaceutical Industry. Croom Helm, London 1977
  • Smith G. H., et al. Physician attitudes toward drug information sources. Am. J. Hosp. Pharm. 1975; 32: 19–25
  • Smith M. C. Small Comfort: A History of the Minor Tranquilizers. Praeger, New York 1985
  • Smith N. A., et al. Effects of intervention on medication compliance in children with asthma. Med. J. Aust. 1986; 144: 119–122
  • Smith N. A., et al. Health beliefs, satisfaction and compliance. Patient Educ. Couns. 1987; 10: 279–286
  • Smith F. J., et al. Community pharmacy: A method of assessing quality of care. Soc. Sci. Med. 1990; 31: 603–607
  • Smith F. J. Community pharmacists and health promotion: A study of consultations between pharmacists and clients. Health Prom. Int. 1992; 7: 249–255
  • Sneddon P. L., et al. Medication compliance in elderly patients. Pharm. J. Aug. 1989; 5: R18–20
  • Sommers I., et al. Assessing the appropriateness of the prescription of psychiatric medications in prison. J. Nerv. Ment. Dis. 1991; 179: 267–273
  • Sondergaard B., et al. The economics of an intensive education programme for asthmatic patients. PharmacoEconomics 1992; 1: 207–212
  • Soumerai S. B., et al. Efficacy and cost-containment in hosptal pharmacotherapy: State of the art and future directions. Health Soc. 1984; 62: 447–474
  • Soumerai S. B., et al. Predictors of physician prescribing change in an educational experiment to improve mediation use. Med. Care 1987; 25: 210–221
  • Soumerai S. B., et al. Improving drug prescribing in primary care: A critical analysis of the experimental literature. Milbank Q. 1989; 67: 268–317
  • Soumerai S. B., et al. Withdrawing payment for nonscientific drug therapy. JAMA 1990; 263: 831–839
  • Spykerboer J. E., et al. Parental knowledge and misconceptions about asthma: A controlled study. Soc. Sci. Med. 1986; 22: 553–558
  • Squier R. W. A model of cmpathic understanding and adherence to treatment regimens in practitioner-patient relationships. Soc. Sci. Med. 1990; 30: 325–329
  • Stanaszek W. F., et al. Self-care habits and disease-state understanding of diabetic patients. Am. J. Hosp. Pharm. 1981; 38: 1337–1339
  • Stanley B., et al. Psychiatric patients' comprehension of consent information. Psychopharmacol. Bull. 1987; 23: 375–378
  • Sternberg J., et al. Use of psychoactive drugs in nursing homes: Prevalence and residents' characteristics. J. Geriatr. Drug Ther. 1990; 4: 47–60
  • Stimson G. V. Obeying doctor's orders: A view from the other side. Soc. Sci. Med. 1974; 8: 97–104
  • Stimson G. V., et al. Going to See the Doctor—The Consultation Process in General Practice. Routledge & Kegan Paul, London 1975
  • Stinson E. R., et al. Survey of the health professionals' information habits and needs. JAMA 1980; 243: 140–143
  • Stitt R. P., et al. Effect of audio-visual and written instruction on drug knowledge, understanding and compliance. Pharm. Management 1979; 151: 134–142
  • Stockwell-Morris L., et al. Patient compliance—An overview. J. Clin. Pharm. Ther. 1992; 17: 283–295
  • Stolley P. D., et al. Prescribing patterns of physicians. J. Chronic Dis. 1969; 22: 395–405
  • Stratton T. P., et al. The role of community pharmacist in providing drug and health information: A pilot survey among the public, physicians, and pharmacists. J. Pharm. Mark. Management 1991; 5(4)3–36
  • Strickland-Hodge B., et al. Typing prescribers by reaction to medical detailing. Chem. Drug. 1981; 215: 352, 346
  • Strull W. M., et al. Do patients want to participate in medical decision making?. JAMA 1984; 252: 2990–2994
  • Svarstad B. Physician-patient communication and patient conformity with medical advice. The Growth of Bureacratic Medicine., D. Mechanic. Wiley, New York 1976; 220–238
  • Sutherland H. J., et al. Are we getting informed consent from patients with cancer?. J. R. Soc. Med. 1990; 83: 439–443
  • Taylor S. J., et al. Introduction to Qualitative Research Methods. The Search for Meanings. Wiley, New York 1984
  • Teklu B. Reasons for failure in treatment of pulmonary tuberculosis in Ethiopians. Tubercle 1984; 65: 17–21
  • Temin P. The effect of prescribing practice on drug-cost reduction. Society and Medication: Conflicting Signals for Prescribers and Patients., J. P. Morgan, et al. Lexington Books, Lexington, MA 1983; 279–288
  • Tessler R., et al. Consumer response to Valium. Drug Ther. 1978; 8: 179–183
  • Topo P., et al. Use of hormone replacement therapy in 1976–89 by 45–64 years old Finnish women. J. Epidemiol. Commun. Health 1991; 45: 277–280
  • Tupin P. J., et al. Further investigation of factors affecting outcome in a doctor's choice treatment setting. J. Dis. Nerv. Syst. 1970; 31: 684–693
  • Tyrer P. J. Benzodiazepines on trial. Br. Med. J. 1984; 288: 1101–1102
  • Tyrer P. J. Dependence as a limiting factor in the clinical use of minor tranquilizers. Pharmacol. Ther. 1988; 36: 173–188
  • Tyrer P. J. Risks of dependence on benzodiazepine drugs: The importance of patient selection. Br. Med. J. 1989; 298: 102–105
  • Tyrer P. J. Withdrawal from hypnotic drugs. Br. Med. J. 1993; 306: 706–708
  • Tyrer P. J., et al. Benzodiazepine withdrawal symptoms and propranolol. Lancet 1981; 1: 520–522
  • Tyrer P. J., et al. Gradual withdrawal of diazepam after long-term therapy. Lancet 1983; 1: 1402–1406
  • Uhlenhuth E. H., et al. Risks and benifits of long-term benzodiazepine use. J. Clin. Psychopharmacol. 1988; 8: 161–167
  • Vainio A. Treatment of terminal cancer pain in Finland: A second look. Acta Anaesthesiol. Scand. 1992; 36: 89–95
  • Valle R. S. The emergence of transpersonal psychology. Existential-Phenomenological Perspectives in Psychology, R. S. Valle, et al. Plenum Press, New York 1989; 257–268
  • Van Putten T. Why do patients with manic-depressive illness stop their lithium?. Compr. Psychiatry 1975; 16: 179–183
  • Vaughan F. Discovering transpersonal identity. J. Hum. Psychol. 1985; 25(3)13–38
  • Victoria S. G. Statistical malpractice in drug promotion: A case-study from Brazil. Soc. Sci. Med. 1982; 16: 707–709
  • Visser A. P. Effects of an information booklet on well-being of hospital patients. Patient Courts. Health Educ. 1980; 2: 51–64
  • Von Cranach M. The psychology study of goal-directed action: Basic issues. The Analysis of Action, M. Von Cranach, et al. Cambridge University Press, Cambridge 1982; 35–74
  • Von Cranach M., et al. Goal-Directed Action. Academic Press, London 1982
  • Wachtel P. L. Interaction cycles, unconscious processes and the person-situation issue. Personality at the Crossroads: Current Issues in Interactional Psychology, D. Magnusson, et al. Erlbaum Assoc., Hillsdale, NJ 1977; 317–331
  • Walsh R. N. The Spirit of Shamanism. Tarcher, Los Angeles 1990
  • Welk P. C. A comparison study of methods to educate patients. Hosp. Pharm. 1975; 10: 240–248
  • Placebo: Theory, Research and Mechanisms, L. White, et al. Guilford Press, New York
  • Whitehorn J. C, et al. Further studies of the doctor as a crucial variable in the outcome of treatment with schizophrenic patients. Am. J. Psychiatry 1960; 117: 215–223
  • WHO. Studies in Drug Utilization. World Health Organization, Copenhagen 1979
  • WHO. Drug Problems in the Sociocultural Context: A Basis for Policies and Programme Planning. Public Health Papers 73. World Health Organization, Geneva 1980
  • Wiederholt J. B., et al. Effectiveness of the FDA-designed patient package insert for benzodiazepines. Am. J. Hosp. Pharm. 1983; 40: 828–834
  • Wiederholt J. B., et al. Verbal consultation regarding prescription drugs: Findings from a statewide study. Med. Care 1992; 30: 159–172
  • Wikblad K., et al. Metabolic control, residual insulin secretion and self-care behaviours in a defined group of patients with type I diabetes. Uppsala J. Med. Sci. 1991; 96: 47–61
  • Wilkinson S. Personal constructs and private explanations. The Psychology of Ordinary Explanations of Social Behaviour, C. Antaki. Academic Press, London 1981; 205–219
  • Williams J. R., et al. Physicians' sources of pharmaceutical information: Changes and implications. J. Pharm. Mark. Management 1991; 5(3)21–36
  • Wilson C. W. M., et al. Influence of different sources of therapeutic information on prescribing by GPs. Br. Med. J. 1963a; 2: 599–604
  • Wilson C. W. M., et al. Patterns of prescribing in practice. Br. Med. J. 1963b; 2: 604–607
  • Wilson C. W. M., . The assessment of prescribing: A study in operational research. Problems and Progress in Medical Care, G. McLuchlan, et al. Nuff. Prov. Hosp. Trust. Oxford Univ. Press. 1964; 173–201
  • Wilson M., et al. Customers' recall of information given in pharmacies. Int. J. Pharm. Pract. 1992; 1: 152–159
  • Winick C. The diffusion of an innovation among physicians in a large city. Sociometry 1961; 24: 384–396
  • Witterborn J. R. Effects of benzodiazepines on psychomotor performance. Br. J Clin. Pharmacol. 1979; 7: 61–67
  • Wittine B. Basic postulates for a transpersonal psychotherapy. Existential-Phenomenological Perspectives in Psychology, R. S. Valle, et al. Plenum Press, New York 1989; 269–287
  • Wood S. L., et al. A self medication scheme for elderly patients improves compliance with their medication regimens. Int. J. Pharm. Pract. 1992; 1: 240–241
  • Woods J. H., et al. Abuse liability of benzodiazepines. Pharmacol. Rev. 1987; 39: 251–419
  • Woods J. H., et al. Benzodiazepines: Use abuse and consequences. Pharmacol. Rev. 1992; 44: 151–338
  • Zifferblatt S. M. Increasing patient compliance through the applied analysis of behavior. Prev. Med. 1975; 4: 173–182
  • Zimmerman M., et al. Diagnosing personality disorder in depressed patients. Arch. Gen. Psychiatry 1988; 45: 733–737
  • Zullich S. G., et al. Impact of triplicate prescription program on psychotropic prescribing patterns in long-term care facilities. DICP 1992; 26: 539–5a46

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.